PQPeng Qiu

Peng Qiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peng Qiu has a total of 100 co-authors. Here are the top co-authors by number of shared publications:

  • Xinwu Lu

    Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

    5 shared publications
  • Chenshu Li

    Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhizaoju Rd, Shanghai, 200011, China

    2 shared publications
  • Deyin Zhao

    Second Ward of General Surgery, Suzhou Municipal Hospital of Anhui Province, Suzhou, China

    2 shared publications
  • Hongji Pu

    Department of Vascular Surgery, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China

    2 shared publications
  • Joanne Ryan

    School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

    2 shared publications
  • Johannes T. Neumann

    School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

    2 shared publications

Latest Publications

  • Hematopoietic loss of Y chromosome and risk of symptomatic peripheral artery disease in men

    by Chenshu Li, Dongdong Tang, Sultana Monira Hussain, Kailang Liu, Peng Qiu, Ruihua Wang, Zhen Zhou

  • Top Cited Papers

    Association between cardiovascular-kidney-metabolic syndrome and risks of 14 age-related health outcomes in primary prevention older population

    by Zhen Zhou, Kevan R. Polkinghorne, Andrew M. Tonkin, Robyn L. Woods, Anping Cai, Sophia Zoungas, Michelle A. Fravel, Michael E. Ernst, Chao Zhu, Mark Nelson, et al.

    Background The American Heart Association (AHA) recently introduced a new clinical entity; the cardiovascular-kidney-metabolic syndrome (CKMS), to promote a multi-disciplinary approach for chronic disease management. This study aims to investigate the relationship between CKMS and major adverse outcomes in older populations in primary care. Methods This study utilized data from 18,367 community-dwelling individuals aged ≥ 65, free from prior cardiovascular disease (CVD). Participants were classified into four CKMS stages (stage 0-no CKMS risk factor to stage 3-high CKMS risk) at baseline based on the AHA definition. The association with 14 health outcomes was analysed using multivariable cause-specific hazard models. Additional stratifications were performed by social disadvantage, inflammation levels, and number of CKMS components within each stage to refine risk staging. Results Over a median follow-up of 8.6 years, the prevalence of CKMS stages 0 to 3 was 2.8%, 8.2%, 52.6%, and 36.0%, respectively. Compared to stage 0, stage 3 associated with all-cause mortality (HR 1.31, 95%CI 1.01–1.69), CVD mortality (3.11, 1.46–6.60), incident total CVD events (2.78, 1.86–4.15), myocardial infarction (2.37, 1.21–4.62), stroke (2.75, 1.50–5.04), heart failure hospitalization (4.56, 1.45–14.37), atrial fibrillation (2.63, 1.61–4.29), cancer (1.31, 1.04–1.64), depression (1.20, 1.04–1.39), and physical disability (1.92, 1.20–3.08). Social disadvantage, high inflammation, and CKMS component count further amplified these associations. No linear trend was observed for cognitive outcomes and non-CVD cause-specific mortality. Conclusion This study is the first to establish relationships between CKMS and multiple age-related outcomes in older adults, providing critical insights for developing holistic approaches to primary care in the aged. Graphical Abstract


  • Open Access

    Targeted inflammatory microenvironment remodeling and NIR-II photothermal therapy for abdominal aortic aneurysm

    by Yijun Liu, Peng Qiu, Huifang Hao, Ang'ANg Ding, Zhaoyu Wu, Jiahao Lei, Zhaoxi Peng, Hongji Pu, Chenlin Zeng, Hongbin Guo, et al.

  • Open Access

    Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older Adults

    by Zhen Zhou, Chris Moran, Anne M. Murray, Sophia Zoungas, Costan Magnussen, Trevor T.-J. Chong, Raj C. Shah, Kerry M. Sheets, Mark Nelson, Chao Zhu, et al.

    Lipid metabolism in older adults is affected by various factors including biological aging, functional decline, reduced physiologic reserve, and nutrient intake. The dysregulation of lipid metabolism could adversely affect brain health. This study investigated the association between year-to-year intraindividual lipid variability and subsequent risk of cognitive decline and dementia in community-dwelling older adults. ASPirin in Reducing Events in the Elderly (ASPREE) was a randomized trial of aspirin, involving 19,114 participants aged 65 years and older from Australia and the United States who were free of dementia and major cognitive impairment. ASPREE-eXTension is the post-trial observational follow-up of participants, currently to a maximum of 11 years. This post hoc analysis included participants who had lipid levels measured at baseline and in years 1, 2, and 3. Year-to-year variability in total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), and triglycerides over the first 3 years was quantified using variability independent of the mean. Individuals who initiated or discontinued lipid-lowering therapy during this period were excluded. Multivariable Cox proportional hazards regression was used to analyze associations with incident dementia, adjudicated by expert panels, and cognitive impairment with no dementia (CIND) confirmed by a battery of cognitive tests, occurring after year 3. A linear mixed model was used for assessing the association with changes in 4 cognitive function domains, including global, memory, processing speed, verbal fluency, and a composite score from baseline to the end of follow-up. The analysis included 9,846 individuals (median [interquartile range] age: 73.9 [71.7-77.3] years, 54.9% female). 509 incident dementia and 1,760 CIND events were recorded over a median follow-up of 5.8 and 5.4 years after variability assessment. The hazard ratios (95% CI) comparing the highest and lowest quartiles of TC and LDL-c variability were 1.60 (1.23-2.08) and 1.48 (1.15-1.91) for dementia and 1.23 (1.08-1.41) and 1.27 (1.11-1.46) for CIND. Higher TC and LDL-c variability was also associated with a faster decline in global cognition, episodic memory, psychomotor speed, and the composite score (all p < 0.001). No strong evidence was found for an association of HDL-c and triglyceride variability with dementia and cognitive change. Tracking variability of TC and LDL-c may serve as a novel biomarker of incident dementia and cognitive decline in older adults.


  • Open Access

    Fluid balance and clinical outcomes in patients with aortic dissection: a retrospective case-control study based on ICU databases

    by Jiahao Lei, Zhuojing Zhang, Yixuan Li, Zhaoyu Wu, Hongji Pu, Zhijue Xu, Xinrui Yang, Ruihua Wang, Peng Qiu, Tao Chen, et al.

    Objectives: Aortic dissection (AD) is a life-threatening condition that requires intensive care and management. This paper explores the role of fluid management in the clinical care of AD patients, which has been unclear despite the substantial existing research that has been conducted on the treatment of AD. Design: A retrospective case-control study using data for AD patients from public databases. Setting: Two public intensive care unit (ICU) databases with hospital courses from the USA, Medical Information Mart for Intensive Care (MIMIC)-IV critical care dataset and the eICU Collaborative Research Database, with data from 2008 to 2019. Participants: A total of 751 adult AD patients with detailed fluid management records from two databases were included. Interventions: The mean 24-hour intake and output were calculated by dividing the total amount of intake and output by the number of days in the ICU, respectively. The mean 24-hour fluid balance was generated by subtracting the output from the intake. Outcome measures: The relationship between the mean 24-hour fluid management and all-cause in-hospital death was assessed through univariate and multivariable regression analyses. Results: A positive correlation was found between mean 24-hour fluid intake and in-hospital mortality among AD patients (OR 1.029, 95% CI (1.018, 1.041), p<0.001), whereas a negative correlation was revealed between mean 24-hour fluid output and in-hospital mortality (OR 0.941, 95% CI (0.914, 0.968), p<0.001). A similar result was found for mean 24-hour fluid balance (OR 1.030, 95% CI (1.019, 1.042), p<0.001), and the cut-off was selected to be 5.12 dL (AUC=0.778, OR 3.066, 95% CI (1.634, 5.753), p<0.001). Conclusions: This study stresses the importance of fluid balance in the clinical care of AD patients and provides new insights for optimising fluid management and monitoring strategies beyond the conventional focus on blood pressure and heart rate management.


  • Open Access

    Validation of the efficacy of the porous medium model in hemodynamic analysis of iliac vein compression syndrome

    by Lingling Wei, Ke Hu, Jiaqiu Wang, Shuang Zhang, Xiaoxiao Yang, Yuanli Chen, Chenshu Li, Xinwu Lu, Kaichuang Ye, Peng Qiu, et al.

    Iliac Vein Compression Syndrome (IVCS) is a common risk factor for deep vein thrombosis in the lower extremities. The objective of this study was to investigate whether employing a porous medium model to simulate the compressed region of an iliac vein could improve the reliability and accuracy of Computational Fluid Dynamics (CFD) analysis outcomes of IVCS. Pre-operative Computed Tomography (CT) scan images of patients with IVCS were utilized to reconstruct models illustrating both the compression and collateral circulation of the iliac vein. A porous medium model was employed to simulate the compressed region of the iliac vein. The agreements of times to peak between discrete phase particles in CFD analysis and contrast agent particles in Digital Subtraction Angiography (DSA) were compared. Furthermore, comparisons were made between the CFD analysis results that incorporated the porous media and those that did not. The results revealed that in the CFD analysis incorporating the porous media model, more than 80% of discrete phase particles reached the inferior vena cava via collateral circulation. Additionally, the concentration variation curve of discrete phase particles demonstrated a high concordance rate of 92.4% compared to that obtained in DSA. In comparison to CFD analysis conducted without the porous medium model, the incorporation of the porous medium model resulted in a substantial decrease in blood flow velocity by 87.5% within the compressed region, a significant increase in pressure gradient of 141 Pa between the inferior vena cava and left iliac vein, and a wider distribution of wall shear stress exceeding 2.0 Pa in collateral vessels rather than in the compressed region. The study suggests that the introduction of a porous medium model improves the hemodynamic analysis of patients with IVCS, resulting in a closer alignment with clinical observations. This provides a novel theoretical framework for the assessment and treatment of patients with IVCS.

  • Open Access

    Unraveling phenotypic heterogeneity in stanford type B aortic dissection patients through machine learning clustering analysis of cardiovascular CT imaging

    by Kun Liu, Deyin Zhao, Lvfan Feng, Zhaoxuan Zhang, Peng Qiu, Xiaoyu Wu, Ruihua Wang, Azad Hussain, Jamol Uzokov, Yanshuo Han


  • Open Access

    Effectiveness, reach, uptake and feasibility of digital health interventions for adults with venous thromboembolism: protocol of a systematic review and meta-analysis

    by Yan Fu, Hongji Pu, Yanjie Wang, Xinwu Lu, Peng Qiu, Min Hu, Yong Cheng

    Introduction Prevention of recurrence after an episode of venous thromboembolism (VTE), and also the post-thrombotic syndrome (PTS), is still a recognised challenge. In this meta-analysis, we will summarise existing evidence to compare intelligent system follow-up and routine follow-up for patients with VTE. Methods and analysis Relevant randomised controlled trials (RCTs) and cohort studies will be included from the following databases: MEDLINE/PubMed, Web of Science and the Cochrane Library. The last search time will be 31 March 2024. Two reviewers will independently identify RCTs and cohort studies according to eligibility and exclusion criteria. The risk of bias of included cohort studies will be assessed with the Newcastle-Ottawa Scale, Methodological Index of Non-Randomised Studies, and the risk of bias of RCTs will be assessed with and Cochrane Collaboration’s tool. The primary outcomes include overall survival rate and PTS incidence rate. The Grades of Recommendations, Assessment, Development and Evaluation tool will be used to assess the level of evidence for outcome from RCTs. RevMan V.5.4 software will be used to pool outcomes. Ethics and dissemination Ethical approval was obtained from Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine Science Research Ethics Committee (SH9H-2023-T466-1). The findings will be disseminated to the public through conference presentations and publication in peer-reviewed scientific journals. PROSPERO registration number CRD42023410644.

  • Open Access

    Establishing and Validating a Morphological Prediction Model Based on CTA to Evaluate the Incidence of Type-B Dissection

    by Yan Fu, Siyi Huang, Deyin Zhao, Peng Qiu, Jiateng Hu, Xiaobing Liu, Xinwu Lu, Lvfan Feng, Min Hu, Yong Cheng

    Background: Many patients with Type B aortic dissection (TBAD) may not show noticeable symptoms until they become intervention and help prevent critically ill, which can result in fatal outcomes. Thus, it is crucial to screen people at high risk of TBAD and initiate the necessary preventive and therapeutic measures before irreversible harm occurs. By developing a prediction model for aortic arch morphology, it is possible to accurately identify those at high risk and take prompt action to prevent the adverse consequences of TBAD. This approach can facilitate timely the development of serious illnesses. Method: The predictive model was established in a primary population consisting of 173 patients diagnosed with acute Stanford TBAD, with data collected from January 2017 and December 2018, as well as 534 patients with healthy aortas, with data collected from April 2018 and December 2018. Explicitly, the data were randomly separated into the derivation set and validation set in a 7:3 ratio. Geometric and anatomical features were extracted from a three-dimensional multiplanar reconstruction of the aortic arch. The LASSO regression model was utilized to minimize the data dimension and choose relevant features. Multivariable logistic regression analysis and backward stepwise selection were employed for predictive model generation, combining demographic and clinical features as well as geometric and anatomical features. The predictive model’s performance was evaluated by examining its calibration, discrimination, and clinical benefit. Finally, we also conducted internal verification. Results: After applying LASSO logistic regression and backward stepwise selection, 12 features were entered into the prediction model. Age, aortic arch angle, total thoracic aorta distance, ascending aorta tortuosity, aortic arch tortuosity, distal descending aorta tortuosity, and type III arch were protective factors, while male sex, hypertension, aortic arch height, and aortic arch distance were risk factors. The model exhibited satisfactory discrimination (AUC, 0.917 [95% CI, 0.890–0.945]) and good calibration in the derivation set. Applying the predictive model to the validation set also provided satisfactory discrimination (AUC, 0.909 [95% CI, 0.864–0.953]) and good calibration. The TBAD nomogram for clinical use was established. Conclusions: This study demonstrates that a multivariable logistic regression model can be used to predict TBAD patients.


  • Open Access

    Prediction of preoperative in-hospital mortality rate in patients with acute aortic dissection by machine learning: a two-centre, retrospective cohort study

    by Zhaoyu Wu, Yixuan Li, Zhijue Xu, Haichun Liu, Kai Liu, Peng Qiu, Tao Chen, Xinwu Lu

    Objectives To conduct a comprehensive analysis of demographic information, medical history, and blood pressure (BP) and heart rate (HR) variability during hospitalisation so as to establish a predictive model for preoperative in-hospital mortality of patients with acute aortic dissection (AD) by using machine learning techniques. Design Retrospective cohort study. Setting Data were collected from the electronic records and the databases of Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and the First Affiliated Hospital of Anhui Medical University between 2004 and 2018. Participants 380 inpatients diagnosed with acute AD were included in the study. Primary outcome Preoperative in-hospital mortality rate. Results A total of 55 patients (14.47%) died in the hospital before surgery. The results of the areas under the receiver operating characteristic curves, decision curve analysis and calibration curves indicated that the eXtreme Gradient Boosting (XGBoost) model had the highest accuracy and robustness. According to the SHapley Additive exPlanations analysis of the XGBoost model, Stanford type A, maximum aortic diameter >5.5 cm, high variability in HR, high variability in diastolic BP and involvement of the aortic arch had the greatest impact on the occurrence of in-hospital deaths before surgery. Moreover, the predictive model can accurately predict the preoperative in-hospital mortality rate at the individual level. Conclusion In the current study, we successfully constructed machine learning models to predict the preoperative in-hospital mortality of patients with acute AD, which can help identify high-risk patients and optimise the clinical decision-making. Further applications in clinical practice require the validation of these models using a large-sample, prospective database. Trial registration number ChiCTR1900025818.